SCHEMBL13065741

SCHEMBL13065741

COc1c2oc3ccccc3nc-2c(C(=O)O)c(-c2ccc(F)cc2)c1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 3/20 0.47
TACR3 P29371 2/20 0.41
ABCG2 Q9UNQ0 5/20 0.41
MAPK14 Q16539 1/20 0.39
BCL9 O00512 1/20 0.39
CTNNB1 P35222 1/20 0.39
ABCB1 P08183 1/20 0.38
KDM4E B2RXH2 4/20 0.38
ALDH1A1 P00352 4/20 0.38
MAPT P10636 3/20 0.38
HPGD P15428 3/20 0.38
HSD17B10 Q99714 3/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CYP3A4 P08684 2/20 0.37
MEN1 O00255 1/20 0.37
THRB P10828 1/20 0.37
KMT2A Q03164 1/20 0.37
CYP2D6 P10635 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13065744 0.93 ABCG2 (0.48) DHODHTACR3ABCG2ABCB1KDM4E
SCHEMBL13065736 0.91 BCL9 (0.44) DHODHABCG2BCL9CTNNB1ABCB1
SCHEMBL13065739 0.91 ALDH1A1 (0.44) DHODHABCG2BCL9CTNNB1ABCB1
SCHEMBL13065730 0.91 ABCG2 (0.50) ABCG2KDM4EALDH1A1MAPTHPGD
SCHEMBL13065734 0.88 SMN1; SMN2 (0.40) DHODHABCG2ABCB1KDM4EALDH1A1
SCHEMBL13065745 0.87 ABCG2 (0.39) DHODHABCG2ABCB1KDM4EALDH1A1
SCHEMBL13065743 0.87 KDM4E (0.40) DHODHABCG2ABCB1KDM4EALDH1A1
SCHEMBL13065732 0.85 MAPK14 (0.45) DHODHMAPK14ABCB1KDM4EMAPT
SCHEMBL13065626 0.85 DHODH (0.43) DHODHTACR3BCL9CTNNB1
SCHEMBL13065742 0.84 KDM4E (0.47) DHODHABCG2ABCB1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9052324-B2 Compounds and assays for controlling Wnt activity ENZO BIOCHEM, INC. (US) 2015-06-09 US disclosed
US-20120322717-A9 Compounds and assays for controlling Wnt activity ENZO BIOCHEM, INC. 2012-12-20 US disclosed
US-20100298200-A1 Compounds and assays for controlling Wnt activity LIU DAKAI 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120322717-A9 Compounds and assays for controlling Wnt activity WNT1, WNT3A, WNT3 DHODH 3278/4885TACR3 3559/4885ABCG2 1063/4885
US-20100298200-A1 Compounds and assays for controlling Wnt activity WNT1, WNT3A, WNT3 DHODH 3278/4885TACR3 3559/4885ABCG2 1063/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.